Use of Intravenous Amiodarone in the Treatment of Nifekalant-Resistant Arrhythmia: A Review of 11 Consecutive Cases with Severe Heart Failure

• Main Authors: Tohru Ujihira (Author), Hiroshi Ito (Author), Hiroshi Morita (Author), Takeshi Tada (Author), Kunihisa Kohno (Author), Yoshiki Hata (Author), Kengo Fukushima Kusano (Author), Koji Nakagawa (Author), Kazufumi Nakamura (Author), Satoshi Nagase (Author), Tohru Ohe (Author), Masato Murakami (Author), Kazumasa Hina (Author)
• Format: Book
• Published: MDPI AG, 2011-05-01T00:00:00Z.
• Subjects: article
• Online Access: Connect to this object online.

Background: Both nifekalant hydrochloride (NIF), a selective IKr blocker, and intravenous amiodarone (AMD), a multi-channel (including IKr blocking) blocker, have been reported to be efficacious for refractory arrhythmias. However, the optimal use of those antiarrhythmic drugs for refractory arrhyth...